These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3119354)

  • 1. Action of tocainide and mexiletine on the excitation threshold of myelinated nerves.
    Tippe A; Linderer EM
    Eur J Pharmacol; 1987 Sep; 141(2):225-33. PubMed ID: 3119354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers.
    De Luca A; Natuzzi F; Lentini G; Franchini C; Tortorella V; Conte Camerino D
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):653-61. PubMed ID: 9053738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Membrane currents and action potentials of myelinated nerve fibers and their modification by diphenylhydantoin and tocainide].
    Schwarz JR
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1988 Sep; 19(3):115-22. PubMed ID: 2460310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of frog skeletal muscle sodium channels by newly synthesized chiral derivatives of mexiletine and tocainide.
    De Luca A; Natuzzi F; Falcone G; Duranti A; Lentini G; Franchini C; Tortorella V; Camerino DC
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Dec; 356(6):777-87. PubMed ID: 9453464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use-dependent blocking action of newly developed lidocaine-analogs on maximum rate of rise of action potentials in guinea pig papillary muscle.
    Toyama J; Kodama I; Kusunoki T; Ishihara T; Hattori Y; Yamada K
    Jpn Heart J; 1987 Mar; 28(2):273-85. PubMed ID: 3110457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine.
    Snyder DW
    J La State Med Soc; 1989 May; 141(5):21-5. PubMed ID: 2499645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antifibrillatory potency of aprindine, mexiletine, tocainide and lignocaine compared on Langendorff-perfused hearts of rabbits and guinea-pigs.
    Almotrefi AA; Baker JB
    J Pharm Pharmacol; 1980 Nov; 32(11):746-50. PubMed ID: 6110721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tocainide blocks Na currents by accumulation of inactivated Na channels.
    Schwarz JR; Grigat G
    Eur J Pharmacol; 1988 Dec; 158(3):267-70. PubMed ID: 2855315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mexiletine and tocainide: orally active congeners of lidocaine.
    Wulf BG
    Clin Pharm; 1983; 2(4):340-6. PubMed ID: 6411416
    [No Abstract]   [Full Text] [Related]  

  • 10. [Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].
    Schmitz W
    Klin Wochenschr; 1980 Sep; 58(18):907-18. PubMed ID: 6110804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of intravenous lidocaine, tocainide, and mexiletine on spontaneously active fibers originating in rat sciatic neuromas.
    Chabal C; Russell LC; Burchiel KJ
    Pain; 1989 Sep; 38(3):333-338. PubMed ID: 2510116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of human liver cytochrome P-450 1A2 by the class IB antiarrhythmics mexiletine, lidocaine, and tocainide.
    Wei X; Dai R; Zhai S; Thummel KE; Friedman FK; Vestal RE
    J Pharmacol Exp Ther; 1999 May; 289(2):853-8. PubMed ID: 10215663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential contribution of sodium channel subtypes to action potential generation in unmyelinated human C-type nerve fibers.
    Lang PM; Hilmer VB; Grafe P
    Anesthesiology; 2007 Sep; 107(3):495-501. PubMed ID: 17721253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of class Ib (lidocaine-like) antiarrhythmic agents for prevention of sustained ventricular tachycardia secondary to coronary artery disease.
    Reiter MJ; Easley AR; Mann DE
    Am J Cardiol; 1987 Jun; 59(15):1319-24. PubMed ID: 3109228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
    Kreeger RW; Hammill SC
    Mayo Clin Proc; 1987 Nov; 62(11):1033-50. PubMed ID: 3118116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine and tocainide: a comparison of antiarrhythmic efficacy, adverse effects, and predictive value of lidocaine testing.
    Murray KT; Barbey JT; Kopelman HA; Siddoway LA; Echt DS; Woosley RL; Roden DM
    Clin Pharmacol Ther; 1989 May; 45(5):553-61. PubMed ID: 2498025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of n-alkanols on the stationary current voltage behavior and action potential of myelinated nerve.
    Tippe A
    Biochim Biophys Acta; 1980 May; 598(1):200-5. PubMed ID: 6968222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of cycle length with the electrophysiological effect of lidocaine, tocainide and verapamil on canine Purkinje fibers.
    Kinnaird AA; Man RY
    Eur J Pharmacol; 1984 Mar; 99(1):63-71. PubMed ID: 6426981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
    Touboul P; Kirkorian G; Atallah G; Moleur P
    Ann Cardiol Angeiol (Paris); 1982 Dec; 31(7):531-7. PubMed ID: 6820620
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
    Pottage A
    Am J Cardiol; 1983 Sep; 52(6):24C-31C. PubMed ID: 6414279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.